All of Us Research Program
Do you want to change the future of health? The Froedtert & MCW health network is part of the National Institutes of Health All of Us Research Program. It has a simple mission — speed up health research breakthroughs. To do this, All of Us is asking one million people to share their health information. Learn how you can help make a difference by joining the All of Us Research Program.
A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury (RISCIS)
The purpose of this trial is to evaluate the efficacy and safety of riluzole in the treatment of patients with acute SCI.
Investigator: Shekar N. Kurpad, MD, PhD
Status: Currently enrolling
TBI, Exception from Informed Consent
The research studies blood flow in aneurysm for the selection of treatment. (NIH RO1: HL115267)
The database is designed specifically to serve as a screening and recruitment tool for stroke researchers in the greater Milwaukee Area, matching stroke survivors willing to contribute to science as research participants with study coordinators seeking to populate their studies with individuals meeting their particular inclusion/exclusion criteria.
This is a randomized, double-blind, placebo-controlled, phase IIa, parallel-group, two-cohort study to define the safety, tolerability, clinical and exploratory biological activity of the chronic administration of Nilotinib in participants with Parkinson’s disease (PD).
Parkinson’s Disease, PD, Nilotinib
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) (FORTITUDE-ALS)
This is a phase 2, multicenter, double-blind, randomized, dose-ranging, placebo-controlled study to evaluate the efficacy, safety and tolerability of CK-2127107 in patients with amyotrophic lateral sclerosis (ALS).
Amyotrophic Lateral Sclerosis, ALS, CK-2127107
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
This is a multicenter, double-blind, placebo-controlled study to assess the efficacy and safety of H.P. Acthar® Gel in the treatment of subjects with amyotrophic lateral sclerosis (ALS). MNK14042068
Amyotrophic Lateral Sclerosis, ALS, Acthar
MRI Study of Intervertebral Disc Degeneration: Evaluation of the Vascular Characteristics in Patients with Chronic Low Back Pain due to Degenerative Disc Disease
Low back pain, degenerative disc disease, healthy volunteers
Spinal Cord Injury
Brain Tissue Bank
This is an international, randomized, double-blind, controlled study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in patients with newly diagnosed, surgically resected, EGFRvIII-positive glioblastoma
Glioblastoma, Brain Tumors, Rindopepimut, vaccination, EGFRvIII
Interstitial Cystitis, IC, Bladder Pain Syndrome, BPS, Myofascial Pelvic Pain, MPP, Chronic Pelvic Pain, CPP, Autonomic Nervous System, ANS, Beta Blocker
Abnormal mitochondrial bioenergetics, functional gastrointestinal disorders, FGID, Cardiopulmonary exercise testing, CPET